Watermark
  Back to Search Results

BGB-A317-210

Completed

Tislelizumab in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-A317-210

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT04318080

EudraCT or EUCT Number Info icon SVG graphic used for tooltips or additional information.

2019

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Plain Language Summary Study Protocol Statistical Analysis Plan

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Plain Language Summary Study Protocol Statistical Analysis Plan